The cancer patient's perspective of COVID-19-induced distress-A cross-sectional study and a longitudinal comparison of HRQOL assessed before and during the pandemic
- PMID: 33973411
- PMCID: PMC8209623
- DOI: 10.1002/cam4.3950
The cancer patient's perspective of COVID-19-induced distress-A cross-sectional study and a longitudinal comparison of HRQOL assessed before and during the pandemic
Abstract
Background: To permit timely mitigation of adverse effects on overall clinical outcome, it is essential to understand how the pandemic influences distress and health-related quality of life (HRQOL) in cancer patients during the coronavirus disease 2019 (COVID-19) pandemic.
Methods: In this cross-sectional study, adult cancer patients, without COVID-19 symptoms, completed a 13-item questionnaire about the pandemic's impacts on distress and everyday-life; associations with age, sex, or impaired HRQOL were then assessed by binary logistic regressions. In a subsample of patients with HRQOL assessment available from both before and during the pandemic, we evaluated the pandemic's impact on longitudinal changes in HRQOL reported within 6 months before versus during the COVID-19 lockdown using McNemar's test, and thresholds for clinical importance.
Results: We consecutively enrolled 240 patients with solid (50%) or hematological (50%) cancers. Median age was 67 years, 46% were females. The majority ranked heeding their health (80%) and keeping their appointment schedule in hospital (78%) as important. Being younger than 60, or aged 60-70 was independently associated with limitations in everyday life (OR = 3.57, p < 0.001; and 2.05, p = 0.038); female individuals and those with restricted emotional functioning were more distressed by the COVID-19 situation (OR = 2.47, p = 0.040; and 3.17, p = 0.019); the latter group was also significantly more concerned about being a patient at risk (OR = 2.21, p = 0.029). Interestingly, in a subsample of patients (n = 47), longitudinal comparisons pre- versus during the pandemic revealed that HRQOL was not substantially affected by the pandemic.
Conclusion: Particularly younger and female cancer patients, and those with impaired emotional functioning are distressed by COVID-19. During the first COVID-19 lockdown, cancer patients remained predominantly resilient. This analysis highlights the need to mitigate distress situations in vulnerable patients and thereby enhance resilience during pandemics.
Keywords: cancer patients; corona virus disease 2019; distress; emotional well-being; health related quality of life; survey.
© 2021 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
Conflict of interest statement
Outside this study, DW reports having received personal fees from Roche, Pfizer, Gilead, Novartis, Abbvie, BMs, Celgene, and Amgen; RS reports research funding and honoraria from Celgene, Teva, and Novartis; WW reports funding or personal fees from Abbvie, AMGEN, BMS‐Celgene, Fujimoto, Gilead, GSK, Incyte, Janssen, Novartis, Merck, MorphoSys, Pfizer, Roche, Sandoz, Sanofi, and Takeda; UG reports personal fees from Bayer Vital, Takeda, MERCK, Merck Serono, Roche, BMS, and MSD. All remaining authors declare no conflicts of interests.
Figures




Similar articles
-
Psychological distress and health-related quality of life in patients after hospitalization during the COVID-19 pandemic: A single-center, observational study.PLoS One. 2021 Aug 11;16(8):e0255774. doi: 10.1371/journal.pone.0255774. eCollection 2021. PLoS One. 2021. PMID: 34379644 Free PMC article.
-
Quality of Life in Patients with Pancreatic Cancer before and during the COVID-19 Pandemic.Int J Environ Res Public Health. 2022 Mar 21;19(6):3731. doi: 10.3390/ijerph19063731. Int J Environ Res Public Health. 2022. PMID: 35329416 Free PMC article.
-
Quality of Life of Patients With Cancer During the COVID-19 Pandemic.In Vivo. 2021 Jan-Feb;35(1):663-670. doi: 10.21873/invivo.12306. In Vivo. 2021. PMID: 33402524 Free PMC article.
-
Assessing patient risk from cancer and COVID-19: Managing patient distress.Urol Oncol. 2021 May;39(5):243-246. doi: 10.1016/j.urolonc.2021.01.023. Epub 2021 Jan 26. Urol Oncol. 2021. PMID: 33558139 Free PMC article. Review.
-
Impact of Covid-19 on health-related quality of life of patients: A structured review.PLoS One. 2021 Oct 28;16(10):e0259164. doi: 10.1371/journal.pone.0259164. eCollection 2021. PLoS One. 2021. PMID: 34710173 Free PMC article. Review.
Cited by
-
New reporting items and recommendations for randomized trials impacted by COVID-19 and force majeure events: a targeted approach.Ann Transl Med. 2023 Jan 15;11(1):2. doi: 10.21037/atm-22-2160. Epub 2023 Jan 4. Ann Transl Med. 2023. PMID: 36760246 Free PMC article.
-
Perspective of Uncertainty and Emotional Responses in Breast Cancer Patients During the COVID-19 Pandemic.SAGE Open Nurs. 2022 Sep 7;8:23779608221124294. doi: 10.1177/23779608221124294. eCollection 2022 Jan-Dec. SAGE Open Nurs. 2022. PMID: 36090540 Free PMC article.
-
Cancer Patients' Experiences with Telehealth before and during the COVID-19 Pandemic in British Columbia.Curr Oncol. 2022 Jun 10;29(6):4199-4211. doi: 10.3390/curroncol29060335. Curr Oncol. 2022. PMID: 35735444 Free PMC article.
-
Impact of facilitating continued accessibility to cancer care during COVID-19 lockdown on perceived wellbeing of cancer patients at a rural cancer center in Rwanda.PLOS Glob Public Health. 2023 Feb 27;3(2):e0001534. doi: 10.1371/journal.pgph.0001534. eCollection 2023. PLOS Glob Public Health. 2023. PMID: 36963043 Free PMC article.
-
The psychological impact of therapeutic changes during the COVID-19-lockdown for gynaecological and breast cancer patients.J Gynecol Obstet Hum Reprod. 2022 Mar;51(3):102311. doi: 10.1016/j.jogoh.2022.102311. Epub 2022 Jan 7. J Gynecol Obstet Hum Reprod. 2022. PMID: 35007776 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical